Hua Medicine (Shanghai) Ltd. (HKG:2552)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.585
+0.025 (0.98%)
Aug 27, 2026, 4:08 PM HKT

Hua Medicine (Shanghai) Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-107.791,106-250.14-211.23-203.51-325.73
Depreciation & Amortization
31.931.933.9635.6731.330.84
Other Amortization
0.570.570.620.570.480.75
Loss (Gain) From Sale of Assets
----0.04-0.08
Stock-Based Compensation
12.1912.1911.8423.9121.2832.7
Other Operating Activities
-9.23-1,245-106.25-90.5-52.537.56
Change in Accounts Receivable
-38.69-38.69-15.02372.75-413.24-13.62
Change in Inventory
5.015.01-82.04-42.72-1.9-
Change in Accounts Payable
49.7749.772.8838.27-0.01-2.51
Change in Unearned Revenue
---756.99366.53-
Change in Other Net Operating Assets
25.7525.75-13.815.721.48-3.03
Operating Cash Flow
-30.53-52.15-417.97889.37-230.11-272.98
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-7.55-7.55-2.83-9.74-4.56-20.2
Sale of Property, Plant & Equipment
---0.07-0.07
Cash Acquisitions
-----0.71-
Sale (Purchase) of Intangibles
---1.03-0.1-22.91-6.39
Other Investing Activities
4.76.8913.917.8523.42-41.71
Investing Cash Flow
-2.84-0.6510.048.08-4.75-68.22

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-112.43133.1520028.92-
Long-Term Debt Repaid
--119.62-44.26-135.74-18.36-16.48
Total Debt Repaid
-119.62-119.62-44.26-135.74-18.36-16.48
Net Debt Issued (Repaid)
-7.19-7.1988.8964.2610.56-16.48
Issuance of Common Stock
22.4622.461.619.891110.35
Other Financing Activities
75.6-6.18-6.78-5.08-0.09-
Financing Cash Flow
90.879.183.7269.0721.48-6.13

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-7.35-3.763.133.6828.78-9.52
Net Cash Flow
50.15-47.47-321.07970.19-184.61-356.85

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-38.08-59.7-420.8879.63-234.67-293.18
Free Cash Flow Growth
------
Free Cash Flow Margin
-5.82%-12.11%-164.44%1148.19%-1333.44%-
Free Cash Flow Per Share
-0.04-0.06-0.430.90-0.24-0.31
Levered Free Cash Flow
-11.55-119.06-268.93249.64-524.53-183.45
Unlevered Free Cash Flow
-6.2-113.96-263.55254.58-522.24-180.98

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
6.186.186.785.080.09-
Change in Working Capital
41.8341.83-107.991,131-27.13-19.17